211 related articles for article (PubMed ID: 29857931)
1. Back to the future - non-canonical functions of complement.
Kemper C; Köhl J
Semin Immunol; 2018 Jun; 37():1-3. PubMed ID: 29857931
[No Abstract] [Full Text] [Related]
2. Targeting complement-mediated immunoregulation for cancer immunotherapy.
Kolev M; Markiewski MM
Semin Immunol; 2018 Jun; 37():85-97. PubMed ID: 29454575
[TBL] [Abstract][Full Text] [Related]
3. Pathogen clearance and immune adherence "revisited": Immuno-regulatory roles for CRIg.
van Lookeren Campagne M; Verschoor A
Semin Immunol; 2018 Jun; 37():4-11. PubMed ID: 29573978
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies.
Taylor RP; Lindorfer MA
Semin Immunol; 2016 Jun; 28(3):309-16. PubMed ID: 27009480
[TBL] [Abstract][Full Text] [Related]
5. The complement system in cancer: Ambivalence between tumour destruction and promotion.
Mamidi S; Höne S; Kirschfink M
Immunobiology; 2017 Jan; 222(1):45-54. PubMed ID: 26686908
[TBL] [Abstract][Full Text] [Related]
6. Role of complement and complement receptor C1qR in the antibody-independent killing of group B streptococcus.
Butko P; Nicholson-Weller A; Wessels MR
Adv Exp Med Biol; 1997; 418():941-3. PubMed ID: 9331805
[No Abstract] [Full Text] [Related]
7. Mechanisms of tumor immunity: the role of antibody and nonimmune effectors.
Shin HS; Johnson RJ; Pasternack GR; Economou JS
Prog Allergy; 1978; 25():163-210. PubMed ID: 362428
[No Abstract] [Full Text] [Related]
8. Complement and phagocytes - A complicated interaction.
Roos D
Mol Immunol; 2015 Nov; 68(1):31-4. PubMed ID: 26597203
[TBL] [Abstract][Full Text] [Related]
9. Influence of complement components on the size and the opsonization of DNA-anti-DNA complexes.
Lamers MC; De Groot ER; Daha MR; Roos D
Scand J Immunol; 1982 Nov; 16(5):389-401. PubMed ID: 7178842
[No Abstract] [Full Text] [Related]
10. Dichotomy of complement system: Tumorigenesis or destruction.
Sinha A; Singh V; Tandon R; Mohan Srivastava L
Immunol Lett; 2020 Jul; 223():89-96. PubMed ID: 32333965
[TBL] [Abstract][Full Text] [Related]
11. Editorial: The Role of Complement in Tumors.
Rolfe BE; Pio R; Woodruff TM; Markiewski MM; Manthey HD
Front Immunol; 2020; 11():139. PubMed ID: 32117286
[No Abstract] [Full Text] [Related]
12. Drivers and regulators of humoral innate immune responses to infection and cancer.
Kumar D; Romero Y; Schuck KN; Smalley H; Subedi B; Fleming SD
Mol Immunol; 2020 May; 121():99-110. PubMed ID: 32199212
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific Fc gamma and complement receptor expression by alveolar macrophages determines relative importance of IgG and complement in promoting phagocytosis of Pseudomonas aeruginosa.
Berger M; Norvell TM; Tosi MF; Emancipator SN; Konstan MW; Schreiber JR
Pediatr Res; 1994 Jan; 35(1):68-77. PubMed ID: 8134202
[TBL] [Abstract][Full Text] [Related]
14. Targeting innate immune pathways in cancer immunotherapy: state of the art.
Mastellos DC
J BUON; 2009 Sep; 14 Suppl 1():S123-30. PubMed ID: 19785054
[TBL] [Abstract][Full Text] [Related]
15. [Immunologic tests: Opsonin].
Suzuki A; Ishii S
Nihon Rinsho; 2005 Jul; 63 Suppl 7():101-3. PubMed ID: 16111200
[No Abstract] [Full Text] [Related]
16. Complement function in mAb-mediated cancer immunotherapy.
Gelderman KA; Tomlinson S; Ross GD; Gorter A
Trends Immunol; 2004 Mar; 25(3):158-64. PubMed ID: 15036044
[No Abstract] [Full Text] [Related]
17. Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells.
Bouhlal H; Chomont N; Haeffner-Cavaillon N; Kazatchkine MD; Belec L; Hocini H
J Immunol; 2002 Sep; 169(6):3301-6. PubMed ID: 12218150
[TBL] [Abstract][Full Text] [Related]
18. Novel mechanisms and functions of complement.
Hajishengallis G; Reis ES; Mastellos DC; Ricklin D; Lambris JD
Nat Immunol; 2017 Nov; 18(12):1288-1298. PubMed ID: 29144501
[TBL] [Abstract][Full Text] [Related]
19. Neutrophils as effector cells for antibody-based immunotherapy of cancer.
van Egmond M; Bakema JE
Semin Cancer Biol; 2013 Jun; 23(3):190-9. PubMed ID: 23287459
[TBL] [Abstract][Full Text] [Related]
20. Innate immune mediators in cancer: between defense and resistance.
Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R
Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
